Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety
Do Young Kim,1 Ju Hyun Kim,2 Won Young Tak,3 Jong Eun Yeon,4 Joon Hyeok Lee,5 Jung Hwan Yoon,6 Youn Jae Lee,7 Byung Seok Lee,8 Byung Hoon Han,9 Han Chu Lee10 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 2Department of Gastroenterology, Gachon University Gil Medica...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/baraclereg-vs-baracludereg-for-48-weeks-in-patients-with-treatment-nai-peer-reviewed-article-DDDT |